Medicare Enrolled
Dr. Eric Luk, M.D.
Medical Oncology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Luk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luk
Dr. Eric Luk is a medical oncology specialist in Asheville, NC, with 12 years of NPI registration. Based on federal Medicare data, Dr. Luk performed 26,721 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Luk received a total of $11,191 from 38 pharmaceutical and/or device companies across 110 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 6% volume in NC
$11,191 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗26,721
Medicare services
Top 6% in NC for medical oncology
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 5,300 | $44 | $157 |
| Anti-nausea injection (aprepitant) | 4,160 | $1 | $6 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,000 | $6 | $25 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
2,340 | $38 | $136 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $64 |
| Iron infusion (Monoferric) | 1,500 | $16 | $74 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,402 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,292 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
796 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 770 | $1 | $41 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
704 | $8 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
314 | $11 | $66 |
| Anti-nausea injection (ondansetron/Zofran) | 288 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
272 | $96 | $421 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
264 | $78 | $654 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
200 | $134 | $550 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
174 | $95 | $390 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
163 | $2 | $7 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
154 | $2 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
146 | $11 | $67 |
| New patient office visit, complex (60-74 min) | 95 | $163 | $673 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
88 | $60 | $214 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
88 | $1 | $4 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
79 | $75 | $210 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
72 | $21 | $103 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
62 | $47 | $208 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
53 | $54 | $234 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
53 | $21 | $164 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
52 | $7 | $126 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $47 | $205 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
46 | $90 | $308 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $66 | $277 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
34 | $15 | $65 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
31 | $71 | $313 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
30 | $1 | $19 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
24 | $3 | $11 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
24 | $24 | $100 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
23 | $19 | $83 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $9 | $40 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $28 | $121 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $132 | $595 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $99 | $406 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
20 | $2 | $9 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
18 | $25 | $135 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | $196 | $1,533 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
17 | $170 | $613 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
16 | $4 | $12 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
16 | $41 | $177 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
15 | $49 | $368 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $120 | $509 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
14 | $3 | $13 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
13 | $1,082 | $4,447 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
13 | $99 | $404 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.6% high complexity
83.2% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,191
Total received (2018-2024)
Avg $1,865/year across 6 years
Top 33% in NC for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
110
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,237
2023
$6,139
2022
$554
2021
$142
2019
$966
2018
$1,152
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$1,071
SOBI, INC
$256
Janssen Biotech, Inc.
$143
PFIZER INC.
$86
Novartis Pharmaceuticals Corporation
$83
Takeda Pharmaceuticals U.S.A., Inc.
$76
Merck Sharp & Dohme LLC
$47
Daiichi Sankyo Inc.
$46
Eisai Inc.
$42
Astellas Pharma US Inc
$42
GENZYME CORPORATION
$41
E.R. Squibb & Sons, L.L.C.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
GlaxoSmithKline, LLC.
$32
Alexion Pharmaceuticals, Inc.
$28
Celgene Corporation
$25
Mirati Therapeutics, Inc.
$24
Incyte Corporation
$23
Genmab U.S., Inc.
$22
ADC Therapeutics America, Inc.
$18
Genentech USA, Inc.
$18
ABBVIE INC.
$17
Karyopharm Therapeutics Inc.
$15
Apellis Pharmaceuticals, Inc.
$15
Top 3 companies account for 65.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novocure Inc.
$6,138
AstraZeneca Pharmaceuticals LP
$1,320
Genentech USA, Inc.
$634
E.R. Squibb & Sons, L.L.C.
$290
SOBI, INC
$256
Amgen Inc.
$207
Pharmacyclics LLC, An AbbVie Company
$199
Medtronic USA, Inc.
$195
Janssen Biotech, Inc.
$176
Merck Sharp & Dohme Corporation
$171
Takeda Pharmaceuticals U.S.A., Inc.
$164
Celgene Corporation
$139
Regeneron Healthcare Solutions, Inc.
$125
EMD Serono, Inc.
$122
TESARO, Inc.
$122
Novo Nordisk Inc
$121
Novartis Pharmaceuticals Corporation
$117
PFIZER INC.
$86
GENZYME CORPORATION
$68
Astellas Pharma US Inc
$59
Merck Sharp & Dohme LLC
$47
Daiichi Sankyo Inc.
$46
Eisai Inc.
$42
Karyopharm Therapeutics Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
GlaxoSmithKline, LLC.
$32
Alexion Pharmaceuticals, Inc.
$28
Seagen Inc.
$27
Mirati Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$23
Incyte Corporation
$23
Genmab U.S., Inc.
$22
Agios Pharmaceuticals, Inc.
$20
ADC Therapeutics America, Inc.
$18
ABBVIE INC.
$17
Heron Therapeutics, Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$12
Top 3 companies account for 72.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Bavencio · Blincyto · DARZALEX · ELREXFIO · ERLEADA · Empaveli · Enhertu · Epkinly · FRUZAQLA · GAZYVA · GILOTRIF · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUMAKRAS · LUTATHERA · Lenvima · NINLARO · NovoSeven RT · NovoTTF-100L · OJJAARA · OPDIVO · OSTEOCOOL RF ABLATION · Optune · Orserdu · PADCEV · PLUVICTO · PYRUKYND · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SUSTOL · SYNAGIS · Somatuline Depot · TAGRISSO · TECENTRIQ · TECVAYLI · ULTOMIRIS · VENCLEXTA · VONJO · Venclexta · XPOVIO · XTANDI · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$70,578
Nearest hospital to ZIP centroid (approximate)
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Luk is a mixed practice specialist, with above-average Medicare volume (top 6% in NC).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Luk experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Luk performed 5,300 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Luk receive payments from pharmaceutical companies?
Yes. Dr. Luk received a total of $11,191 from 38 companies across 110 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luk's costs compare to other medical oncologists in Asheville?
Dr. Luk's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Asheville
Browse medical oncologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NC
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NC
Which NC medical oncologists receive the most from drug and device companies.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology